Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
65.30    0.30 (0.46%)
Bid:
65.20
Ask:
65.50
Spread: 0.30 (0.46%)
Market Cap: £576.88m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Total Voting Rights

30 Sep 2021 16:11

RNS Number : 6141N
IP Group PLC
30 September 2021
Β 

FOR RELEASE ON

30 September 2021

Β 

IP Group plc - Voting Rights and Capital - Month End Disclosure

Pursuant to Disclosure and Transparency Rule 5.6.1:

As at the date of this announcement the issued share capital of IP Group plc comprisedΒ 1,063,033,287 ordinary shares of 2p each. There were no shares held in treasury.

The total number of voting rights in IP Group plc is therefore 1,063,033,287.

This information may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, the share capital of IP Group plcΒ under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

For further information, please contact:

IP Group plc www.ipgroupplc.com Greg Smith, Chief Financial Officer +44 (0) 20 7444 0050Liz Vaughan-Adams, Communications +44 (0) 20 7444 0062/+44 (0) 7979 853802

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TVRURRVRANUKOAR
Date   Source Headline
25th Jun 20263:21 pmRNSForm 8.3 - IP Group PLC
25th Jun 20263:06 pmRNSForm 8.3 - IP Group plc
25th Jun 20262:27 pmRNSForm 8.3 - IP Group plc
25th Jun 20262:08 pmGNWForm 8.3 - IP Group Plc
25th Jun 20261:57 pmEQSForm 8.3 - The Vanguard Group, Inc.: IP Group plc
25th Jun 20261:10 pmRNSForm 8.3 IP Group PLC
25th Jun 202611:21 amRNS20260624_IP Group PLC_8.5 EPT RI_UK_MLI
25th Jun 202610:47 amRNSForm 8.3 IP Group Plc
25th Jun 20267:00 amRNSForm 8.3 - IP Group plc
24th Jun 20263:20 pmRNSForm 8.3 - IP Group plc
24th Jun 20263:19 pmRNSForm 8.3 - IP Group plc
24th Jun 20263:17 pmRNSForm 8.3 - IP Group plc
24th Jun 20263:16 pmRNSForm 8.3 - IP Group plc
24th Jun 20262:48 pmRNSForm 8.3 - IP Group plc
24th Jun 20262:20 pmEQSForm 8.3 - The Vanguard Group, Inc.: IP Group plc
24th Jun 20262:12 pmGNWForm 8.3 - IP Group Plc
24th Jun 202611:53 amRNSForm 8.3 - IP Group PLC
24th Jun 202611:30 amRNSForm 8.5 (EPT/RI) - IP Group plc
24th Jun 202611:27 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - IP GROUP PLC - Ordinary Shares
24th Jun 202611:08 amRNSForm 8.5 (EPT/RI) - IP Group PLC
24th Jun 202610:29 amRNSForm 8.3 IP Group Plc
23rd Jun 20263:54 pmRNSForm 8.3 - IP Group PLC
23rd Jun 20263:20 pmRNSForm 8.3 - IP Group plc
23rd Jun 20263:10 pmRNSForm 8.3 - IP Group plc (OPD)
23rd Jun 20262:46 pmRNSForm 8.3 - IP Group plc
23rd Jun 20262:22 pmGNWForm 8.3 IP Group Plc
23rd Jun 20262:07 pmRNSForm 8.3 IP Group Plc
23rd Jun 20261:57 pmRNSResponse to Possible Offer for IP Group plc
23rd Jun 202611:22 amRNSForm 8.5 (EPT/NON-RI) - IP Group plc
23rd Jun 202611:19 amRNSForm 8.5 (EPT/RI) - IP Group plc
23rd Jun 20269:49 amRNSForm 8.5 (EPT/RI) - IP Group PLC
22nd Jun 20264:27 pmRNSDisclosure Table
22nd Jun 20264:06 pmRNSStatement re Possible Offer
18th Jun 20261:54 pmRNSResult of AGM
16th Jun 20267:00 amRNS-RIstesso starts trial of leramistat in sarcopenia
11th Jun 20267:00 amRNSHolding(s) in Company
3rd Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
28th May 20267:00 amRNSHolding(s) in Company
13th May 20265:30 pmRNSNotice of AGM
12th May 20269:10 amRNS-REnterprise reports positive results from P2 trial
11th May 20264:25 pmRNSHolding(s) in Company
11th May 20264:19 pmRNSHolding(s) in Company
7th May 20267:00 amRNSAppointment of Chair Designate
23rd Apr 202612:18 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNS-RFirst Light announces £25m successful first close
15th Apr 20265:00 pmRNSAnnual Financial Report
14th Apr 20269:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.